These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 542176)

  • 21. Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetics.
    Redman DR; Prescott LF
    Diabetes; 1973 Mar; 22(3):210-1. PubMed ID: 4689295
    [No Abstract]   [Full Text] [Related]  

  • 22. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glycemia and plasma insulin under the influence of tolbutamide and HB 419 in normal and diabetic persons].
    Quabbe HJ; Kliems G
    Journ Annu Diabetol Hotel Dieu; 1969; 10():301-9. PubMed ID: 5376989
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
    Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
    J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantitative approach to drug compliance of diabetics].
    Gaillard C; Dayer P; Balant L; Assal JP; Fabre J
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1738-42. PubMed ID: 6658420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tolbutamide serum levels im chloramfenicol treated diabetic females (author's transl)].
    Brunová E; Slabochová Z; Platilová H; Pavlík F; Grafnetterová J; Dvorácek K
    Cas Lek Cesk; 1974 Nov; 113(48):1484-7. PubMed ID: 4434421
    [No Abstract]   [Full Text] [Related]  

  • 28. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific protection by sulfhydryl groups against inhibition of urease by hypoglycaemic drugs (author's transl)].
    García JM; Molina J; Herrera J
    Rev Esp Fisiol; 1978 Jun; 34(2):145-8. PubMed ID: 694201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L; Kristensen M; Hansen M; Siersbaek-Nielsen K
    Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An absence of interaction of sulfametrol-trimethoprim with insulin or sulphonylurea derivatives in diabetics (author's transl)].
    Kaspar L
    Wien Klin Wochenschr; 1980 Apr; 92(8):276-9. PubMed ID: 6996341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients.
    Ober KF
    Eur J Clin Pharmacol; 1974 Jul; 7(4):291-4. PubMed ID: 4853129
    [No Abstract]   [Full Text] [Related]  

  • 34. [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)].
    Bottermann P; Schweigart U; Ermler R
    Med Klin; 1976 Sep; 71(36):1423-8. PubMed ID: 958105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Half life of intravenous tolbutamide in the serum of patients in medical wards.
    Sotaniemi EA; Huhti E
    Ann Clin Res; 1974 Jun; 6(3):146-54. PubMed ID: 4844125
    [No Abstract]   [Full Text] [Related]  

  • 36. [The influence of clofibrate on glucose metabolism in diabetes mellitus without endogenous hypertriglyceridemia (author's transl)].
    Vogelberg KH; Scherff R; Schulze-Schleppinghoff B
    Arzneimittelforschung; 1982; 32(4):413-6. PubMed ID: 7049189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction of phenylbutazone and tolbutamide in man].
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Orv Hetil; 1979 Nov; 120(47):2843-4. PubMed ID: 394087
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic control of tolbutamide metabolism in humans.
    Scott J; Henderson AD; Poffenbarger PL
    Adv Exp Med Biol; 1979; 119():361-70. PubMed ID: 495292
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
    Zilly W; Breimer DD; Richter E
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):219-27. PubMed ID: 1233266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.